HIV & Co-Infections

HIV co-infection worsens the histological course of other viral infections, such as HCV by increasing and accelerating the risk of cirrhosis or leading to rare but lethal fibrosing cholestatic hepatitis. Discover the latest research on HIV co-infection.

October 26, 2021
Open Access

Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study.

BMC Infectious Diseases
Joseph Baruch BalukuStavia Turyahabwe
October 26, 2021

Subjective donor deferral as a tool for increased blood transfusion safety: A cross-sectional observational study.

Health Science Reports
Juliane Girão de MouraDenise Menezes Brunetta
October 26, 2021
Open Access

Tuberculosis endotypes to guide stratified host-directed therapy.

Andrew R DiNardoReinout Van Crevel
October 26, 2021

A randomized, blinded, placebo-controlled trial of De Simone formulation probiotic during HIV-associated suboptimal CD4+ T cell recovery.

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Rodney K RousseauRupert Kaul
October 26, 2021

High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Stella Maris NanyongaRonald Kiguba
October 26, 2021

Associations between Central Obesity and Life-Long Antiviral Therapy in Adults Living with HIV Acquired from Early Childhood.

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Seynt Jiro SahagunColleen M Hadigan
October 23, 2021
Case Report

COVID-19, HIV-Associated Cryptococcal Meningitis, Disseminated Tuberculosis and Acute Ischaemic Stroke: A Fatal Foursome.

Infection and Drug Resistance
Felix BongominFrederick Nakwagala
October 23, 2021

Comparing the Efficacy of Chemical Cautery to Cryosurgery on CD4+ Status of HIV Patients with Condyloma Acuminata.

Clinical, Cosmetic and Investigational Dermatology
Prasetyadi MawardiTatar Sumandjar
October 23, 2021
Open Access

HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases.

Frontiers in Medicine
Zhimeng ChengNansheng Cheng
October 23, 2021
Open Access

Lignosulfonate Rapidly Inactivates Human Immunodeficiency and Herpes Simplex Viruses.

Kunihiko FukuchiYuji Kikkawa
October 23, 2021

Peripheral artery disease and physical function in women with and without HIV.

Emily R CedarbaumPhyllis C Tien
October 24, 2021
Case Report
Open Access

COVID-19 in Patients with Active Tuberculosis.

Monika Kozińska, Ewa Augustynowicz-Kopeć
October 24, 2021

Ginkgolic Acid Inhibits Coronavirus Strain 229E Infection of Human Epithelial Lung Cells.

Maimoona S BhuttaRonen Borenstein
October 24, 2021
Open Access

Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis.

International Journal of Environmental Research and Public Health
Melese Yeshambaw TeferiHawult Taye Adane

Sign up to follow this feed and discover related papers.

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

© 2021 Meta ULC. All rights reserved